What is the proliferative phase of the endometrium?

A woman's endometrium will undergo different changes throughout the menstrual cycle. Clinically, this change is called the secretory phase and proliferative phase of the endometrium. Under normal circumstances, the thickness of a woman's endometrium during the proliferative phase is 8-12MM, which is most conducive to the implantation of the fertilized egg. However, some women have abnormal endometrial thickness during the proliferative phase. This is the so-called proliferative change of the endometrium, which will directly affect women's fertility. What exactly is the proliferative change of the endometrium?

Endometrial proliferative changes may affect fertility! Endometrial proliferative changes are endometrial lesions! They can cause irregular menstruation, etc. and may affect fertility! Endometrial hyperplasia refers to a group of proliferative lesions occurring in the endometrium, mainly occurring in women of childbearing age. The cause of endometrial hyperplasia is mainly related to long-term estrogen stimulation. Histologically, endometrial hyperplasia is classified into simple hyperplasia, complex hyperplasia and atypical hyperplasia; according to the severity of the lesion, it is divided into mild, moderate and severe degrees. Endometrial hyperplasia is common in middle-aged women over 35 years old. Menstrual disorders are one of the prominent symptoms of this disease, which are often manifested as irregular vaginal bleeding, infrequent menstruation, amenorrhea or continuous bleeding after a period of amenorrhea. It is generally called anovulatory functional uterine bleeding. In addition to vaginal bleeding, infertility is also the main symptom of patients with anovulatory dysfunctional uterine bleeding during the reproductive period.

The treatment of atypical endometrial hyperplasia must first determine the diagnosis and the cause of the atypical hyperplasia, including whether there is polycystic ovary, functional ovarian tumors or other endocrine dysfunction. Those with any of the above conditions should receive targeted treatment. At the same time, symptomatic treatment can be started for atypical endometrial hyperplasia, using drug therapy or surgical treatment. The choice of these two treatment options should be based on age, type of endometrial hyperplasia, fertility requirements, etc.

Now you are clear about what is happening when the endometrium shows proliferative changes. Here, we need to remind all patients that although treatment is the key, we must first rule out the possibility of the disease becoming cancerous. If the disease is combined with uterine cancer, we must consider removing the uterus, which will cause great harm to women, especially those who have not given birth.